Paracetamol (5 mmol kg(-1), i.p.) caused liver damage in rats as indicated
by increased plasma aspartate aminotransferase (AST), alanine aminotransfer
ase (ALT) and glutamate dehydrogenase (GDH) activities. No change in plasma
bilirubin or creatinine was noted. An equimolar dose of nitroparacetamol (
a nitric oxide (NO)-releasing derivative of paracetamol) did not alter plas
ma levels of any of the markers of liver/kidney damage. No difference in pl
asma or liver paracetamol was apparent in animals injected with paracetamol
or nitroparacetamol. These results indicate that NO released from nitropar
acetamol exhibits hepatoprotective activity in these animals and suggest th
at nitroparacetamol may therefore be considered as a safer alternative to p
aracetamol in the clinic.